药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dimethyltryptamine
Aripiprazole lauroxil
The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Glasdegib.
Dimethyltryptamine
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Glasdegib.
Dimethyltryptamine
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Glasdegib.
Dimethyltryptamine
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Glasdegib.
Dimethyltryptamine
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Glasdegib.
Dimethyltryptamine
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Glasdegib.
Dimethyltryptamine
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Glasdegib.
Dimethyltryptamine
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Glasdegib.
Dimethyltryptamine
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Glasdegib.
Dimethyltryptamine
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Glasdegib.
Dimethyltryptamine
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Glasdegib.
Dimethyltryptamine
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Glasdegib.
Dimethyltryptamine
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Glasdegib.
Dimethyltryptamine
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Glasdegib.
Dimethyltryptamine
Triclabendazole
The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Glasdegib.
Dimethyltryptamine
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Glasdegib.
Dimethyltryptamine
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Glasdegib.
Dimethyltryptamine
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Glasdegib.
Dimethyltryptamine
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Glasdegib.
Dimethyltryptamine
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Glasdegib.